Insider Transactions in Q3 2024 at Edgewise Therapeutics, Inc. (EWTX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2024
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
20,922
-86.55%
|
$564,894
$27.63 P/Share
|
|
Sep 23
2024
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,922
+46.39%
|
$0
$0.71 P/Share
|
|
Sep 20
2024
|
Joanne M. Donovan CMO |
SELL
Open market or private sale
|
Direct |
7,162
-33.0%
|
$200,536
$28.29 P/Share
|
|
Sep 20
2024
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
50,000
-93.89%
|
$1,400,000
$28.37 P/Share
|
|
Sep 20
2024
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.43%
|
$0
$0.71 P/Share
|
|
Sep 20
2024
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
75,000
-45.3%
|
$2,100,000
$28.88 P/Share
|
|
Sep 20
2024
|
Alan J Russell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+46.09%
|
$0
$0.18 P/Share
|
|
Sep 20
2024
|
R Michael Carruthers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
125,092
-58.42%
|
$3,502,576
$28.58 P/Share
|
|
Sep 20
2024
|
R Michael Carruthers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
96,068
+41.37%
|
$96,068
$1.93 P/Share
|
|
Sep 20
2024
|
Behrad Derakhshan Chief Business Officer |
SELL
Open market or private sale
|
Direct |
42,068
-73.56%
|
$1,219,972
$29.03 P/Share
|
|
Sep 20
2024
|
Behrad Derakhshan Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,068
+42.38%
|
$42,068
$1.93 P/Share
|